What is the maximum recommended dose of venlafaxine (Effexor) per day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Recommended Dose of Venlafaxine (Effexor)

The maximum recommended dose of venlafaxine is 375 mg per day, though doses above 225 mg should be reserved for more severely depressed patients who do not respond to lower doses. 1

Dosing Guidelines and Recommendations

  • The recommended starting dose for venlafaxine is 75 mg/day, administered in two or three divided doses, taken with food 1
  • Dose increases should be made in increments of up to 75 mg/day at intervals of no less than 4 days 1
  • For most outpatients with depression, there is no evidence of usefulness for doses greater than 225 mg/day 1
  • More severely depressed inpatients may respond to higher doses, with clinical trials showing a mean effective dose of 350 mg/day in this population 1
  • For neuropathic pain management, the efficacious dosage range is typically 150-225 mg/day, with a minimum effective dose of 75 mg/day 2

Dose-Response Relationship

  • A positive dose-response effect has been demonstrated with doses of up to 375 mg/day, with a minimum effective dose of 75 mg/day 3
  • In treatment-resistant depression, studies have used mean daily doses of 260 mg/day with good efficacy 4
  • Higher doses may be more effective in some patients, but come with increased risk of side effects 5

Safety Considerations with Higher Doses

  • Blood pressure monitoring is important, as venlafaxine can cause modest increases in blood pressure, particularly at higher doses 2, 6
  • Cardiac conduction abnormalities have been reported in a small number of patients, requiring caution in those with cardiac disease 2, 6
  • The most common side effects include:
    • Digestive system: nausea, dry mouth, constipation 7, 4
    • Nervous system: dizziness, somnolence, insomnia 7, 4
    • Other: sweating, abnormal ejaculation 7, 4
  • At doses higher than 375 mg/day (up to 600 mg/day), patients may experience increased severity of side effects, particularly fatigue, concentration difficulties, sleepiness/sedation, and memory problems 5

Special Populations

  • For patients with hepatic impairment: reduce total daily dose by 50% in mild to moderate hepatic impairment; further reductions may be necessary in patients with cirrhosis 1
  • For patients with renal impairment: reduce total daily dose by 25% in mild to moderate renal impairment; reduce by 50% in patients undergoing hemodialysis 1
  • For elderly patients: no specific dose adjustment is recommended based on age alone, but caution is advised when increasing the dose 1

Discontinuation

  • A withdrawal syndrome can occur if venlafaxine is abruptly discontinued; the medication should be tapered when discontinuing 2
  • Tapering over 10-14 days is generally recommended to limit withdrawal symptoms 8

Important Caveats

  • When used for neuropathic pain, cardiovascular adverse events may limit venlafaxine's use in patients with diabetes 8
  • While some studies have investigated doses up to 600 mg/day, these exceed the FDA-approved maximum dose of 375 mg/day 1, 5
  • Careful monitoring for side effects is essential when using doses at the upper end of the recommended range 5

References

Guideline

Dose-Response Relationship and Safety Considerations for Venlafaxine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacologic profile and efficacy of venlafaxine.

International clinical psychopharmacology, 1995

Research

Tolerability of high-dose venlafaxine in depressed patients.

Journal of psychopharmacology (Oxford, England), 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.